Form 4: Eterna Therapeutics Inc. Insider Buys Shares in Private Placement
SEC Form 4
Charles Cherington, a director and 10% owner of Eterna Therapeutics Inc., acquired 3,768,397 shares of common stock through a private placement on April 2, 2025.
Summary
- On April 2, 2025, Charles Cherington, a director and 10% owner of Eterna Therapeutics Inc., acquired 3,768,397 shares of the company's common stock through a private placement.
- The purchase price was $0.1046 per share.
- Following the transaction, Cherington directly owns 20,401,602 shares of Eterna Therapeutics Inc.
- Cherington also received 5,082 shares of common stock on December 3, 2024, as a dividend payment related to the Series A Preferred Stock.
Sentiment
Score: 7
Explanation: Insider buying is generally viewed positively, suggesting confidence in the company's future. However, the specific context of the purchase (private placement) and the size of the stake need to be considered.
Positives
- An insider's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored as an indicator of management's confidence in the company's prospects. It's a common practice, and the details are publicly disclosed to ensure transparency.
Stakeholder Impact
- The insider purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/03/2024 | Issuer paid a dividend to all holders of record of its Series A Preferred Stock on such date of $0.05 per share of Series A Preferred Stock. Reporting Person received 5,082 shares of the Issuer's common stock. |
| 04/02/2025 | Reporting person acquired 3,768,397 shares of the Issuer's Common Stock pursuant to a private placement offering by the Issuer. |
| 04/04/2025 | Date of signature for the Form 4 filing. |
Keywords
Eterna Therapeutics Inc., insider trading, Form 4, share acquisition, private placement, Charles Cherington, ERNA, common stock, dividend
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.